Please use this identifier to cite or link to this item:

Title: A 2-mercaptoethanol-ELISA for the diagnosis of canine visceral leishmaniasis.
Authors: Veloso, Laura
Semião-Santos, Saul
Andrade, Paulo
Melo, Márcia
Martins, Luís
Marinho, Artur
Almeida, José
Harith, Abdalla
Keywords: Leishmaniose
Issue Date: 23-Sep-2012
Publisher: Sociedade Brasileira de Medicina Tropical
Citation: Veloso LB, Semião-Santos SJ, Andrade PP, Melo AM, Martins L, Marinho AA, Almeida JÁ, Harith AE. 2012. A 2-mercaptoethanol-ELISA for the diagnosis of canine visceral leishmaniasis. Proceedings of the XVIII International Congress for Tropical Medicine and Malaria and XLVIII Congress of the Brazilian Society of Tropical Medicine. P69:486. Brazil, 23 – 27 September.
Abstract: Following procedures of antigen preparation similar to those described for the direct agglutination test (DAT), an IgG ELISA employing promastigotes of Leishmania infantum was developed for the diagnosis of canine visceral leishmaniasis (CVL). The newly developed β-ME-ELISA was also compared with an ELISA version using instead of β-ME-treated, trypsin-treated promastigote (TRYP-ELISA) antigen. While in comparison with DAT (31/31 = 100%) slightly lower sensitivity (29/31 = 93.5%) was demonstrated for the β-ME-ELISA developed in dogs with confirmed CVL, evidently higher sensitivity was estimated in the same canine population by comparison with the TRYP-ELISA (27/31 = 87.1%). When challenged against conditions other than CVL: including babesiosis, ehrlichiosis and Chagas’s disease, a specificity of 97.5% was estimated for β-ME-ELISA as compared to 100% or 94.1% for DAT and TRYP-ELISA respectively. In an endemic population manifesting CVL clinical suspicion (n=38), results obtained with the β-ME ELISA were more concordant (33/38 = 86.3%) with those of the DAT than the TRYP-ELISA (27/38 = 71.1%). In this group of unconfirmed CVL, the incorporated β-ME treated promastigote antigen has demonstrated also higher sensitivity (29/31 = 93.5% or 62/69 = 88.9%) in comparison with that of its trypsinized equivalent (27/31 = 87.1% or 54/69 = 78.2%). Our current results implicate the application of β-ME ELISA in the laboratory to support results obtained in the field with the DAT.
Type: article
Appears in Collections:MED - Artigos em Livros de Actas/Proceedings

Files in This Item:

File Description SizeFormat
Poster Veloso LB et al ICTMM 2012.jpg877.07 kBJPEGView/OpenRestrict Access. You can Request a copy!
FacebookTwitterDeliciousLinkedInDiggGoogle BookmarksMySpaceOrkut
Formato BibTex mendeley Endnote Logotipo do DeGóis 

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.


Dspace Dspace
DSpace Software, version 1.6.2 Copyright © 2002-2008 MIT and Hewlett-Packard - Feedback
UEvora B-On Curriculum DeGois